Pre-transplant utilization of sorafenib is not associated with increased complications after liver transplantation-Reference-Cited by-同舟云学术

Pre-transplant utilization of sorafenib is not associated with increased complications after liver transplantation

Published:2013-05-23 Issue:7 Volume:26 Page:734-739
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Frenette Catherine T.¹,Boktour Maha²,Burroughs Sherilyn G.²,Kaseb Ahmed³,Aloia Thomas A.⁴,Galati Joseph⁵,Gaber Ahmed O.²,Monsour Howard⁶,Ghobrial Rafik M.²

Affiliation:

1. Center for Organ and Cell Transplantation; Scripps Clinic; San Diego; CA

2. Department of Surgery; The Methodist Hospital; Houston; TX

3. Department of Gastrointestinal Oncology; The University of Texas MD Anderson Cancer Center; Houston; TX

4. Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston; TX

5. Texas Liver Specialists; Houston; TX

6. Department of Medicine; The Methodist Hospital; Houston; TX

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12117/fullpdf

Reference19 articles.

1. Estimating the world cancer burden: GLOBOCAN 2001;Parkin;Int J Cancer,2001

2. Hepatocellular carcinoma incidence, morality, and survival trends in the Unites States from 1975 to 2005;Altekruse;J Clin Oncol,2009

3. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

4. An early regional experience with expansion of Milan criteria for liver transplant recipients;Guiteau;Am J Transplant,2010

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New horizons in liver transplantation for hepatocellular carcinoma;South African Journal of Surgery;2024-06

2. Downstaging Hepatocellular Carcinoma before Transplantation;Surgical Oncology Clinics of North America;2024-01

3. Transplant Oncology: An Emerging Discipline of Cancer Treatment;Cancers;2023-11-09

4. Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy?;Hepatobiliary & Pancreatic Diseases International;2023-02

5. Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation;Transplant International;2022-11-09